Why Choose MOTS-c?
MOTS-c is a naturally occurring mitochondrial-derived peptide, first discovered in 2015 . Unlike peptides encoded by nuclear DNA, MOTS-c is encoded within the mitochondrial 12S ribosomal RNA gene, making it a unique research tool for studying mitochondria-nucleus communication and cellular energy regulation . It has garnered significant interest in metabolic, aging, and neuroprotection research.
The History & Origins
MOTS-c is a 16-amino-acid peptide that is translated in the cytoplasm from a transcript exported from the mitochondria, using the standard genetic code . Its discovery by Dr. Changhan David Lee and colleagues at the University of Southern California in 2015 represented a paradigm shift, showing that the mitochondrial genome could encode functional, hormone-like peptides that exert systemic effects .
The peptide is highly conserved across a wide range of species, including humans, chimpanzees, mice, rats, dogs, and dolphins, indicating a fundamental biological role . A key discovery followed in 2018 when the same research group found that MOTS-c could translocate to the cell nucleus in response to metabolic stress and regulate nuclear gene expression . This was the first worldwide report showing a mitochondrial protein moving to the nucleus to regulate an independent genome, establishing MOTS-c as a key auxiliary gene expression regulator .
How They Work: Distinct Mechanisms
MOTS-c operates through several pathways that make it a valuable tool for metabolic, aging, and inflammatory research.
AMPK Pathway Activation
-
Primary signaling mechanism — MOTS-c activates AMP-activated protein kinase (AMPK), a master cellular energy sensor . Studies have shown that MOTS-c significantly increases AMPK phosphorylation, which is blocked by AMPK inhibitors, confirming the pathway’s role in its effects .
-
Energy metabolism regulation — Through AMPK activation, MOTS-c enhances insulin sensitivity, stimulates fatty acid β-oxidation, and improves glucose utilization, promoting metabolic flexibility under energy stress conditions .
Nuclear Translocation and Gene Expression
-
Mitochondria-to-nucleus communication — MOTS-c translocates to the nucleus during metabolic stress to regulate nuclear gene expression . This represents a novel retrograde signaling pathway where mitochondria directly influence nuclear transcription programs.
Cellular Protection and Neuroprotection
-
Neuropathic pain research — MOTS-c has demonstrated dose-dependent antinociceptive effects in mouse models of neuropathic pain, inhibiting microglia activation and neuronal oxidative damage in the spinal cord via the AMPK pathway . Notably, these effects were retained even when microglial activation was inhibited, indicating that the primary target is neuronal rather than microglial .
-
Blood-brain barrier protection — In sepsis models, MOTS-c has been shown to preserve blood-brain barrier integrity by upregulating tight junction proteins (claudin-5, occludin, ZO-1), reducing permeability, and increasing survival rates .
Senescence and Diabetes Research
-
Islet cell protection — MOTS-c levels decrease with aging and cellular senescence in pancreatic islet cells . Treatment with MOTS-c has been shown to prevent pancreatic islet cell senescence and delay diabetes progression in multiple mouse models, including chronological aging, type 1 diabetes (NOD mice), and type 2 diabetes models . In humans, circulating MOTS-c levels are lower in type 2 diabetes patients compared with healthy controls .
Exercise Mimetic Properties
-
Enhanced physical performance — In mouse studies, MOTS-c administration has been shown to mimic some effects of exercise, increasing insulin sensitivity and preventing obesity even when animals consumed a high-fat diet . Treated mice maintained more lean muscle mass, built up less body fat, and voluntarily ran faster and for nearly twice as long on a treadmill
